Search

everythinglearnresearchcommunity

for

Search:↓

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

PRP injections increased hair density in men with hair loss but didn't work for everyone and more research is needed.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Acne severity is not related to the type or severity of androgenetic alopecia.

Effective treatments for common hair loss are limited and may have side effects, leading to patient disappointment and treatment discontinuation.

Many women with postadolescent acne also have hormonal imbalances and are at higher risk for metabolic issues.

Women with a certain type of hair loss have more copper in the back of their head than the front, and treatment can normalize hair but not copper levels.

The document concludes that injecting platelet-rich plasma can effectively treat androgenetic alopecia, a type of hair loss.

The paper suggests that telogen effluvium, a type of hair loss, may be a long-lasting condition triggered by stress or illness in people whose hair growth is unusually synchronized.

Pilose antler extract helps hair grow in mice with a type of hair loss by speeding up the growth phase.

A gene mutation in Lama3 is linked to a common type of hair loss.

Removing a methyl group from the ITGAV gene speeds up bone formation in a specific type of bone disease model.

Shorter telomeres in white blood cells may increase the risk of a common type of hair loss.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Herbal alternatives like saw palmetto and green tea may offer safe, effective treatment for hormonal hair loss.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Over 150 new molecules with biological activities were found in traditional herbal medicines, some with potential for new drug development.

Early diagnosis and treatment, like topical minoxidil, can prevent hair loss in children.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

Finasteride is a safe and effective long-term treatment for male hair loss, especially when started early.

Integrin alphavbeta6 is important for wound healing and hair growth, and blocking it may improve these processes.